Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
11/2003
11/20/2003US20030215466 Which is incapable of reproduction within human cell lines; for treatment of human immunodeficency virus
11/20/2003US20030215460 Methods and compositions for inducing an immune response
11/20/2003US20030215450 Anti-rank ligand monoclonal antibodies useful in treatment of rank ligand mediated disorders
11/20/2003CA2492394A1 Induction of antigen specific immunologic tolerance
11/20/2003CA2485655A1 Recombinant fowlpox virus
11/20/2003CA2485527A1 Substituted pyrroline kinase inhibitors
11/20/2003CA2485400A1 Methylated immunostimulatory oligonucleotides and methods of using the same
11/20/2003CA2485256A1 Pathogen vaccines and methods for using the same
11/20/2003CA2484835A1 Complex of organic medicines and beta-cyclodextrin derivatives and its preparing process
11/20/2003CA2484607A1 Methods and compositions for inducing an immune response
11/20/2003CA2484266A1 Cancer vaccines and methods of using the same
11/20/2003CA2484144A1 Eif-5a nucleic acids for inhibiting apoptosis
11/20/2003CA2480488A1 Novel diazabicyclic biaryl derivatives
11/20/2003CA2462203A1 Methods and products for enhancing immune responses using imidazoquinoline compounds
11/20/2003CA2451081A1 Adenosine a<sb>3</sb> receptor modulators
11/19/2003EP1362916A2 Human tumor necrosis factor delta and epsilon
11/19/2003EP1362911A1 Transgenic animal having drug metabolism enzyme gene and utilization thereof
11/19/2003EP1362853A1 Styrene derivatives and process for production thereof
11/19/2003EP1362849A2 Process for production of piperidine derivatives
11/19/2003EP1362848A1 Process for the preparation of vitamin D derivatives
11/19/2003EP1362597A1 Antigenic peptides derived from telomerase
11/19/2003EP1362596A2 Inhibitor of stem cell proliferation and uses thereof
11/19/2003EP1362592A1 Use of 2-hydroxy-4-trifluoromethylbenzoic acid derivatives as inhibitors of the activation of the nuclear transcription factor NF-kB
11/19/2003EP1362105A2 Anti-interferon-alpha antibodies
11/19/2003EP1362061A2 Antibodies that bind both bcma and taci
11/19/2003EP1362050A1 Pyrimidine derivatives for inhibition of cell-proliferation
11/19/2003EP1362047A2 Indazolyl-substituted pyrroline compounds as kinase inhibitors
11/19/2003EP1362045A2 2-thio-substituted imidazole derivatives and the use thereof in the pharmaceutical industry
11/19/2003EP1362044A1 Phthalazinone-piperidino-derivatives as pde4 inhibitors
11/19/2003EP1362043A1 Lactone compounds as novel photoinitiators
11/19/2003EP1361892A1 Binding domain-immunoglobulin fusion proteins
11/19/2003EP1361880A2 6-substituted pyrido-pyrimidines
11/19/2003EP1361876A2 Novel cannabimimetic ligands
11/19/2003EP1179005B1 Steroid compounds with a c17-alkyl side chain and an aromatic a-ring for use in therapy
11/19/2003EP1117628B1 2, 4-pentadienoic acid derivatives having selective activity for retinoid x (rxr) receptors
11/19/2003EP1086124B1 Novel cyclosporins
11/19/2003EP1017667B1 2-Amino-6-methyl-7-acetyl-tetraline and pharmaceutical compositions for the prevention and therapeutic treatment of inflammatory and/or autoimmune pathologies
11/19/2003EP0914111B1 Prevention and treatment of cachexia and anorexia
11/19/2003EP0851753B1 Aerosol compositions
11/19/2003EP0809499B1 Certain 1,4,5-tri-substituted imidazole compounds useful as cytokine
11/19/2003EP0766559B1 Cannabinoid receptor antagonists
11/19/2003EP0733066B1 Pretargeting methods and compounds
11/19/2003CN1457259A Method for preventing and curing diseases of immune system and remedy for carrying out said method
11/19/2003CN1457257A Extended native chemical ligation
11/19/2003CN1456349A Biological preparation containing marine active substance and use thereof
11/19/2003CN1456254A Preparation of immunoregulation effervescent tablets
11/19/2003CN1127985C Fowl marek's disease vaccine synergist and its preparation
11/19/2003CN1127983C Inmunization adjusting anti-inflamation agent
11/19/2003CN1127963C Oral liquid of chitosan and lucid ganoderma and its preparing process
11/19/2003CN1127950C Antirheumatic agents
11/18/2003US6649742 Fusion protein comprising gelonin and a antibody fused thereto; cytolysis; use in treatment of cancer, autoimmune and graft-versus-host disease
11/18/2003US6649737 Human galactosyltranferases
11/18/2003US6649642 Succinate derivative compounds useful as cysteine protease inhibitors
11/18/2003US6649640 Isoxazole compositions useful as inhibitors of ERK
11/18/2003US6649633 Nicotinamide biaryl derivatives useful as inhibitors of PDE4 isozymes
11/18/2003US6649612 Biphenyl derivatives substituted with an aromatic or heteroaromatic radical, and pharmaceutical and cosmetic compositions containing them
11/18/2003US6649611 Potent and selective inhibitors of chemokine binding to its receptor CCR1 found on inflammatory and immunomodulatory cells (preferably leukocytes and lymphocytes).
11/18/2003US6649608 Cyclin-dependent serine/threonine and focal adhesion kinase inhibitors
11/18/2003US6649604 Analgesics; antidiabetic agents; antiinflamamtory agents
11/18/2003US6649589 Blocking tumor necrosis factor activity with soluble cytokine receptor, monoclonal antibody or tetracycline derivative
11/18/2003US6649391 Isolated polynucleotide encoding a polypeptide of given sequence; dephosphorylates MAP(mitogen activated protein)-kinase; used for modulating cell proliferation, differentiation and survival
11/18/2003US6649172 5-(p-carboxybenzyloxy)-2-oxybenzaldehyde derivatives; vaccine adjuvants
11/18/2003US6649168 Pharmaceutical compositions comprising TGF-beta
11/18/2003US6649166 Peptides and proteins for desensitizing subjects allergic to bee venom and compositions containing same
11/18/2003US6649164 (RANK); RANK is a member of the TNF superfamily; used to regulate an immune response
11/17/2003CA2429483A1 Immunointeractive molecules
11/13/2003WO2003093422A2 Novel tissue factor targeted antibodies as anticoagulants
11/13/2003WO2003093318A1 Novel antibody binding tcr and tirc7 and its use in therapy and diagnosis
11/13/2003WO2003093297A2 Protein kinase modulators and methods of use
11/13/2003WO2003093287A1 Novel method for preparing alpha-glycosylceramides, novel alpha-glycosylceramide derivatives and their uses
11/13/2003WO2003093268A1 7-aminoimidazotriazones
11/13/2003WO2003093267A1 7-aryl-3,9-diazabicyclo(3.3.1)non-6-ene derivatives and their use as renin inhibitors in the treatment of hypertension, cardiovascular or renal diseases
11/13/2003WO2003093249A1 Thiazolidinones and the use thereof as polo-like kinase inhibitors
11/13/2003WO2003093248A1 Heteroaryl substituted biphenyl derivatives as p38 kinase inhibitors
11/13/2003WO2003093237A1 2,6-quinolinyl and 2,6-naphthyl derivatives, processes for preparing them and their uses as vla-4 inhibitors
11/13/2003WO2003093231A2 Tetrahydropyranyl cyclopentyl tetrahydroisoquinoline modulators of chemokine receptor activity
11/13/2003WO2003092740A1 Non-viral gene delivery system
11/13/2003WO2003092739A1 Non-viral gene delivery system
11/13/2003WO2003092732A1 Ph-sensitive polymer
11/13/2003WO2003092722A1 7-HYDROXY-16α-FLUORO-5-ANDROSTEN-17-ONES AND 7-HYDROXY-16α-FLUORO-5-ANDROSTAN-17-ONES AND DERIVATIVES THEREOF
11/13/2003WO2003092714A2 Peptide variants of ige constrained by beta-lactam bond
11/13/2003WO2003092709A1 Method for producing preparations rich in tocotrienol
11/13/2003WO2003092708A1 Antitumor agents with the use of hsv
11/13/2003WO2003092703A1 Methods and compositions for inhibition or irritation by disaccharide and metal ions
11/13/2003WO2003092699A1 Use of conjugated estrogens in combination with trimegestone in hormone replacement therapy
11/13/2003WO2003092686A1 Inhibitors of histone deacetylase
11/13/2003WO2003092681A1 Use of (3-(2-ethylphenyl)-5-methoxyphenyl)-1h-[1,2,4]-triazole for the treatment of autoimmune diseases
11/13/2003WO2003092678A1 1-substituted imidazole derivatives as nos inhibitors
11/13/2003WO2003092672A1 Method of inhibiting rejection of transplanted material
11/13/2003WO2003092657A1 Microparticles bearing cells and active substances
11/13/2003WO2003092654A1 Formulations limiting spread of pulmonary infections
11/13/2003WO2003092624A2 Use of heat shock proteins to enhance efficacy of antibody therapeutics
11/13/2003WO2003092608A2 Methionine aminopeptidase-2 inhibitors and methods of use thereof
11/13/2003WO2003092605A2 Protease inhibitors
11/13/2003WO2003092602A2 Novel tissue factor targeted thrombomodulin fusion proteins as anticoagulants
11/13/2003WO2003092599A2 Formulation of a mixture of free-b-ring flavonoids and flavans as a therapeutic agent
11/13/2003WO2003092588A2 4-azasteroid derivatives as androgen receptor modulators
11/13/2003WO2003092586A2 Tetrahydropyranyl cyclopentyl tetrahydropyridopyridine modulators of chemokine receptor activity
11/13/2003WO2003092580A2 Methods and compositions for treatment of central and peripheral nervous system disorders and novel compounds useful therefor
11/13/2003WO2003068968A3 Mutated gene coding for a lat protein and the biological applications thereof
1 ... 670 671 672 673 674 675 676 677 678 679 680 681 682 683 684 685 686 687 688 689 690 ... 1172